Good morning :)
Place Order
Add to Watchlist

Procter & Gamble Health Ltd

PGHL

Procter & Gamble Health Ltd

PGHL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹9,303 cr, stock is ranked 582
Low RiskStock is 1.56x as volatile as Nifty
5,663.150.70% (-40.20)
5,663.150.70% (-40.20)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹9,303 cr, stock is ranked 582
Low RiskStock is 1.56x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹9,303 cr, stock is ranked 582
Low RiskStock is 1.56x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
42.7317.294.64%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.536.560.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue1,424.751,026.831,127.601,248.011,166.891,172.60
Raw Materialssubtract444.47310.39344.55358.99329.69848.55
Power & Fuel Costsubtract19.0912.9714.7012.888.50
Employee Costsubtract182.93153.66167.56206.17215.16
Selling & Administrative Expensessubtract257.28173.99203.91196.86181.66
Operating & Other expensessubtract136.68111.70116.01130.04130.44
Depreciation/Amortizationsubtract29.4530.0427.0828.1027.4026.69
Interest & Other Itemssubtract0.000.800.420.770.720.69
Taxes & Other Itemssubtract100.7756.4860.8584.7372.3478.93
EPS153.07106.51115.98138.24121.08131.17
DPS230.00130.0052.5095.00260.00250.00
Payout ratio1.501.220.450.692.151.91

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2019

Annual Report Unavailable

 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Procter & Gamble Health Ltd46.2917.294.64%
Sun Pharmaceutical Industries Ltd45.356.470.75%
Cipla Ltd28.514.380.89%
Torrent Pharmaceuticals Ltd68.4516.540.84%

Price Comparison

Compare PGHL with any stock or ETF
Compare PGHL with any stock or ETF
PGHL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding51.82%10.45%4.39%6.61%26.74%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep7.15%7.38%7.59%6.24%6.40%6.61%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Procter & Gamble Health Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Nippon India Small Cap Fund - Growth - Direct Plan

Growth
3.7892%0.57%-0.01%151/234 (-74)
ICICI Prudential Smallcap Fund - Growth - Direct Plan

Growth
1.9347%2.15%0.21%68/130 (0)
UTI AMC LTD # UTI MF-UTI MNC FUND DIRECT PLAN GROWTH PLAN GROWTH

Growth
1.3376%4.17%0.22%6/52 (+2)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 4.64%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹46.39 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateNov 28, 2024

Final
Final | Div/Share: ₹60.00

Dividend/Share

60.00

Ex DateEx Date

Nov 28, 2024

Cash Dividend

Ex DateEx DateFeb 14, 2024

Interim
Interim | Div/Share: ₹50.00

Dividend/Share

50.00

Ex DateEx Date

Feb 14, 2024

Cash Dividend

Ex DateEx DateFeb 14, 2024

Special
Special | Div/Share: ₹150.00

Dividend/Share

150.00

Ex DateEx Date

Feb 14, 2024

Cash Dividend

Ex DateEx DateNov 23, 2023

Final
Final | Div/Share: ₹50.00

Dividend/Share

50.00

Ex DateEx Date

Nov 23, 2023

Cash Dividend

Ex DateEx DateFeb 13, 2023

Interim
Interim | Div/Share: ₹45.00

Dividend/Share

45.00

Ex DateEx Date

Feb 13, 2023

News & Opinions
Spotlight
P&G Health hits 52 week high as Q2 PAT jumps 26% YoY to Rs 82 cr

Profit before tax in Q2 FY25 stood at Rs 111.4 crore, up 26.51% as against Rs 88.05 crore posted in same quarter last year. Total expenses were at Rs 205.29 crore in Q2 September 2024, down 7.91% on YoY basis. Cost of materials consumed stood at Rs 48.17 crore (down 44.82% YoY) while employee benefits expenses came in at Rs 46.22 crore (down 23.77% YoY) during the period under review. Milind Thatte, Managing Director, P superiority (across product, package, brand communication, retail execution, and value), constructive disruption and an agile accountable organization'. He further added, 'We are dedicated to enhancing consumer awareness programs and strengthening our relationships with our customers and stakeholders. We continue to invest in initiatives that address the evolving needs of both consumers and healthcare professionals, along with strengthening our go-to-market model. We have also strengthened our reach, distribution, and retail execution, positioning us for long-term competitiveness'. Procter & Gamble Health (P&G Health) is one of India's largest VMS companies, manufacturing and marketing vitamins, minerals, and supplements products that include Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion. The counter has hit a 52-week high at Rs 5,730.75 in today's intra-day session.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Procter & Gamble Health standalone net profit rises 25.56% in the September 2024 quarter

Net profit of Procter & Gamble Health rose 25.56% to Rs 82.33 crore in the quarter ended September 2024 as against Rs 65.57 crore during the previous quarter ended September 2023. Sales rose 2.78% to Rs 313.41 crore in the quarter ended September 2024 as against Rs 304.93 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales313.41304.93 3 OPM %36.3929.08 - PBDT117.1794.53 24 PBT111.4088.05 27 NP82.3365.57 26 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Procter & Gamble Health to hold board meeting

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 4 November 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Procter & Gamble Health schedules AGM

Procter & Gamble Health announced that the 57th Annual General Meeting (AGM) of the company will be held on 5 December 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Market Overview
Sensex, Nifty end with minor gains; broader mkt rallies

The domestic equity benchmarks ended with small gains on Thursday. The Nifty settled above the 24,800 level. Consumer durables, PSU bank and FMCG shares advanced while media, IT and pharma shares declined. Trading was volatile due to weekly F&O series expiry today. As per provisional closing, the barometer index, the S&P BSE Sensex, gained 147.89 points or 0.18% to 81,053.19. The Nifty 50 index added 41.30 points or 0.17% to 24,811.50. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index added 0.67% and the S&P BSE Small-Cap index gained 0.47%. The market breadth was strong. On the BSE, 2,462 shares rose and 1,501 shares fell. A total of 90 shares were unchanged. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, slipped 2.49% to 13. Economy: The latest HSBC Flash PMI survey, compiled by S&P Global, also highlighted a sharp upturn in new business intakes, solid job creation and upbeat expectations towards growth prospects. On the price front, there were softer increases in both input costs and selling prices. The headline HSBC Flash India Composite Output Index ' a seasonally adjusted index that measures the month-on-month change in the combined output of India's manufacturing and service sectors ' stood at 60.5 in August, little changed from 60.7 in July and pointing to a sharp rate of expansion that was above its long-run trend level (54.6). There was a softer increase in manufacturing industry output and a fractionally stronger rise in activity across the service economy. Yet, the former led the upturn. The HSBC Flash India Manufacturing PMI ' a single-figure snapshot of factory business conditions calculated from measures of new orders, output, employment, supplier delivery times and stocks of purchases ' slipped from 58.1 in July to a three-month low of 57.9 in August. The latest reading was nevertheless above the historical average (54.0) and signaled a strong improvement in the health of the sector. Goods producers reported the first decline in outstanding business volumes in just under a year, while service providers indicated a thirty-second consecutive monthly rise. The pace of accumulation was mild among the latter, and the weakest since February. The HSBC Flash India Services PMI rose to 60.4 in August from 60.3 in July. IPO Update : The initial public offer (IPO) of Orient Technologies received 10,87,68,096 bids for shares as against 74,49,846 shares on offer, according to stock exchange data at 13:15 IST on Thursday (21 August 2024). The issue was subscribed 14.60 times. The issue opened for bidding on Wednesday (21 August 2024) and it will close on Friday (23 August 2024). The price band of the IPO is fixed between Rs 195 to Rs 206 per share. An investor can bid for a minimum of 72 equity shares and in multiples thereof. Buzzing Index: The Nifty Consumer Durables index added 0.86% to 40,671.15. The index advanced 7.56% in nine consecutive trading sessions. Kalyan Jewellers India (up 10.38%), Century Plyboards (India) (up 4.03%), Blue Star (up 2.57%), Bata India (up 1.83%), Rajesh Exports (up 1.53%), Titan Company (up 1.24%), Dixon Technologies (India) (up 0.99%), Voltas (up 0.69%), Amber Enterprises India (up 0.52%) advanced. On the other hand, V-Guard Industries (down 2.3%), Kajaria Ceramics (down 1.45%) and Crompton Greaves Consumer Electricals (down 1.28%) declined. Stocks in Spotlight: Procter & Gamble Health shed 0.15% after the pharma company's net profit tumbled 43.73 % to Rs 16.78 crore in Q4 June 2024 as against Rs 29.82 crore recorded in Q4 June 2023. Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, owing to changes in the go-to-market model. Indian Renewable Energy Development of India (IREDA) surged 8.37% after the company's board said that it will meet on 29 August 2024, to consider raising funds up to Rs 4,500 crore through different modes. Zomato fell 0.84%. The company said that its board approved to enter into share purchase agreement (SPA) with One97 Communication (Paytm), Wasteland Entertainment (WEPL) and Orbgen Technolgies (WEPL) to acquire their entertainment ticketing business. Rail Vikas Nigam (RVNL) added 1.23%. The company said that it has signed a memorandum of understanding (MoU) with Dhaya Maju Infrastructure (Asia) Sdn Berhad (DMIA) to expand its operations into the ASEAN market. GAIL (India) fell 0.99%. The company said that it has signed Memorandum of Understanding (MoU) with Petron Scientech Inc (Petron) to jointly explore setting up of a 500 Kilo Tons per Annum (KTA) bio-ethylene plant in India. Aarti Drugs jumped 5.95% after the company announced that its board will meet on Monday, 26 August 2024, to consider a proposal for buyback of fully paid-up equity shares of the company. Welspun Enterprises advanced 1.68% after the company said that its material subsidiary, Welspun Michigan Engineers (WMEL) received letter of acceptance (LOA) from the Brihanmumbai Municipal Corporation (BMC), aggregating to Rs 159.75 crore. Transformers and Rectifiers (India) (TRIL) was locked in 5% upper circuit after the company announced that it has bagged two export orders worth $16.80 million (approximatelty equal to Rs 141 crore). Global Markets: Europeans market advanced while Asian stocks ended higher on Thursday. Japan's stock market bucked the regional trend, supported by stronger-than-expected services sector data. The au Jibun Bank flash Japan manufacturing purchasing managers' index (PMI) rose to 49.5 in August from 49.1 in July. On Wednesday, U.S. stock markets closed higher, extending a positive streak. The S&P 500 and the Nasdaq advanced for the ninth day in the last 10 trading sessions with the former gaining 0.42% and the tech-heavy Nasdaq adding 0.57%. The Dow Jones saw modest gain of 0.14%. The minutes from the Federal Reserve's latest meeting reinforced expectations for a rate cut in September, with a majority of FOMC members indicating that such a move would be appropriate based on current economic indicators. But optimism over a rate cut was offset by data showing a severe downward revision in U.S. payrolls data in the year to March 2024, drumming up concerns that a slowing labor market could spur a potential recession in the world's biggest economy. The Bureau of Labor Statistics revised down March 2024's employment gains by 818,000 positions earlier in the session, as part of the agency's annual benchmark review of payroll data. Investors now eagerly await Federal Reserve Chair Jerome Powell's speech at the Jackson Hole Symposium on Friday.Powered by Capital Market - Live

3 months agoCapital Market - Live
Live Market Update
Broader market outperforms; European mkt opens higher

The headline equity indices traded with decent gains in afternoon trade. The Nifty hovered above the 24,800 level. Consumer durables, PSU bank and private bank shares advanced while IT, oil & gas and media stocks declined. Trading was volatile due to weekly F&O series expiry today. At 13:30 IST, the barometer index, the S&P BSE Sensex, gained 155.19 points or 0.27% to 81,124.04. The Nifty 50 index added 47.10 points or 0.19% to 24,817.30. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index added 0.41% and the S&P BSE Small-Cap index gained 0.42%. The market breadth was strong. On the BSE, 2,459 shares rose and 1,399 shares fell. A total of 135 shares were unchanged. Economy: The latest HSBC 'flash' PMI survey, compiled by S&P Global, also highlighted a sharp upturn in new business intakes, solid job creation and upbeat expectations towards growth prospects. On the price front, there were softer increases in both input costs and selling prices. The headline HSBC Flash India Composite Output Index ' a seasonally adjusted index that measures the month-on-month change in the combined output of India's manufacturing and service sectors ' stood at 60.5 in August, little changed from 60.7 in July and pointing to a sharp rate of expansion that was above its long-run trend level (54.6). There was a softer increase in manufacturing industry output and a fractionally stronger rise in activity across the service economy. Yet, the former led the upturn. The HSBC Flash India Manufacturing PMI ' a single-figure snapshot of factory business conditions calculated from measures of new orders, output, employment, supplier delivery times and stocks of purchases ' slipped from 58.1 in July to a three-month low of 57.9 in August. The latest reading was nevertheless above the historical average (54.0) and signaled a strong improvement in the health of the sector. Goods producers reported the first decline in outstanding business volumes in just under a year, while service providers indicated a thirty-second consecutive monthly rise. The pace of accumulation was mild among the latter, and the weakest since February. The HSBC Flash India Services PMI rose to 60.4 in August from 60.3 in July. Gainers & Losers: Grasim Industries (up 2.46%), Tata Consumer Products (up 2.09%), Bharti Airtel (up 1.67%), ICICI Bank (up 1.41%) and Hero MotoCorp (up 1.22%) were major Nifty gainers. Tata Motors (down 1.40%), NTPC (down 1.25%) Mahindra & Mahindra (down 1.24%), Dr Reddy's Laboratories (down 1.20%) and Tata Consultancy Services (down 1.11%) were major Nifty losers. Stocks in Spotlight: Procter & Gamble Health slipped 2.42% after the pharma company's net profit tumbled 43.73 % to Rs 16.78 crore in Q4 June 2024 as against Rs 29.82 crore recorded in Q4 June 2023. Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, owing to changes in the go-to-market model. Indian Renewable Energy Development of India (IREDA) surged 9.90 after the company's board said that it will meet on 29 August 2024, to consider raising funds up to Rs 4,500 crore through different modes. Zomato shed 0.63%. The company said that its board approved to enter into share purchase agreement (SPA) with One97 Communication (Paytm), Wasteland Entertainment (WEPL) and Orbgen Technolgies (WEPL) to acquire their entertainment ticketing business. Rail Vikas Nigam (RVNL) rose 0.98%. The company said that it has signed a memorandum of understanding (MoU) with Dhaya Maju Infrastructure (Asia) Sdn Berhad (DMIA) to expand its operations into the ASEAN market. Aarti Drugs jumped 6.49% after the company announced that its board will meet on Monday, 26 August 2024, to consider a proposal for buyback of fully paid-up equity shares of the company. Welspun Enterprises advanced 1.45% after the company said that its material subsidiary, Welspun Michigan Engineers (WMEL) received letter of acceptance (LOA) from the Brihanmumbai Municipal Corporation (BMC), aggregating to Rs 159.75 crore. Transformers and Rectifiers (India) (TRIL) was locked in 5% upper circuit after the company announced that it has bagged two export orders worth $16.80 million (approximatelty equal to Rs 141 crore). Global Markets: Europeans market advanced while most Asian stocks traded higher on Thursday, primarily driven by a downward revision in U.S. payrolls data. This revision raised concerns about a potential economic slowdown in the world's largest economy. Japan's stock market bucked the regional trend, supported by stronger-than-expected services sector data. The au Jibun Bank flash Japan manufacturing purchasing managers' index (PMI) rose to 49.5 in August from 49.1 in July. On Wednesday, U.S. stock markets closed higher, extending a positive streak. The S&P 500 and the Nasdaq advanced for the ninth day in the last 10 trading sessions with the former gaining 0.42% and the tech-heavy Nasdaq adding 0.57%. The Dow Jones saw modest gain of 0.14%. The minutes from the Federal Reserve's latest meeting reinforced expectations for a rate cut in September, with a majority of FOMC members indicating that such a move would be appropriate based on current economic indicators. But optimism over a rate cut was offset by data showing a severe downward revision in U.S. payrolls data in the year to March 2024, drumming up concerns that a slowing labor market could spur a potential recession in the world's biggest economy. The Bureau of Labor Statistics revised down March 2024's employment gains by 818,000 positions earlier in the session, as part of the agency's annual benchmark review of payroll data. Investors now eagerly await Federal Reserve Chair Jerome Powell's speech at the Jackson Hole Symposium on Friday. Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, owing to changes in the go-to-market model. Profit before exceptional items and tax was at Rs 43.02 crore in the June quarter, down 2.52% from Rs 44.13 crore reported in the same period a year ago. The exceptional items include impairment charges amounting to 20.19 crore. On full year basis, the company's net profit dropped 12.42% to Rs 200.98 crore on 6.37% fall in revenue to Rs 1,151.26 crore in FY24 over FY23. Milind Thatte, managing director, P&G Health India, said, Our results this quarter reflect the typically seasonality of shipments during this period. In addition, we've made choices to strengthen the execution of our integrated strategy with the deployment of a transformed go-to-market model. We're confident these changes will deliver superior reach, distribution, retail execution and improve our long-term competitiveness. Our strategy remains anchored on a focused product portfolio where performance is a key driver of brand preference, superiority (across product performance, packaging, brand communication, retail execution and value), constructive disruption and an agile, accountable organization. This integrated strategy continues to guide our efforts to generate sustainable, balanced top- and bottom-line growth and value creation. We continue to navigate the evolving market dynamics with resilience and explore innovative solutions to ensure our trusted, quality brands remain the preferred choice for healthcare professionals and consumers alike,' he added. Meanwhile, the company's board recommended a final dividend of Rs 60 per equity share for the financial year ended 30 June 2024. The dividend will be paid by 25 December 2024, on approval of the members at the 57th annual general meeting. Procter & Gamble Health (P&G Health) is one of India's largest VMS companies, manufacturing and marketing vitamins, minerals, and supplements products that include Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion. Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Procter & Gamble Health standalone net profit declines 43.73% in the June 2024 quarter

Net profit of Procter & Gamble Health declined 43.73% to Rs 16.78 crore in the quarter ended June 2024 as against Rs 29.82 crore during the previous quarter ended June 2023. Sales declined 5.74% to Rs 283.88 crore in the quarter ended June 2024 as against Rs 301.18 crore during the previous quarter ended June 2023. For the full year,net profit declined 12.42% to Rs 200.98 crore in the year ended June 2024 as against Rs 229.47 crore during the previous year ended June 2023. Sales declined 6.37% to Rs 1151.26 crore in the year ended June 2024 as against Rs 1229.62 crore during the previous year ended June 2023. ParticularsQuarter EndedYear EndedJun. 2024Jun. 2023% Var.Jun. 2024Jun. 2023% Var. Sales283.88301.18 -6 1151.261229.62 -6 OPM %17.0015.05 -26.5826.40 - PBDT50.1850.63 -1 320.91342.30 -6 PBT43.0244.13 -3 293.51314.20 -7 NP16.7829.82 -44 200.98229.47 -12 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on 21 August 2024, inter alia, have recommended the final dividend of Rs 60 per equity Share (i.e. 600%) , subject to the approval of the shareholders.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Procter & Gamble Health to pay final dividend

Procter & Gamble Health announced that final dividend of Rs 60 per share for FY 2024 will be paid by 25 December 2024. Powered by Capital Market - Live

3 months agoCapital Market - Live